16:12 EST 10x Genomics sees FY23 revenue $670M-$690M, consensus $702.06M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TXG:
- 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
- Canaccord still bullish on 10x Genomics, PacBio despite reducing 2024 estimates
- 10x Genomics price target lowered to $60 from $65 at Deutsche Bank
- 10x Genomics price target raised to $55 from $45 at Barclays
- 10x Genomics’s preliminary Q4 results ahead of Street estimates, says Canaccord